Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This study is a prospective, randomized, parallel-controlled clinical trial, primarily aimed at evaluating the level of body weight improvement of megestrol acetate combined with standard treatment compared with standard treatment in the first-line treatment of non-small cell lung cancer.
Epistemonikos ID: a4f494a26abd0d75bcc35819d8d4bf8cb7896daa
First added on: Mar 18, 2026